Does Aetna Cover Propecia? What You Need to Know About Insurance and Finasteride

Does Aetna Cover Propecia?
At a glance
- Aetna classification / Propecia is listed as a cosmetic exclusion in most Aetna commercial and Medicare plans
- Brand Propecia retail cost / approximately $90 to $120 per month without insurance
- Generic finasteride 1 mg cost / as low as $4 to $15 per month at major pharmacies
- FDA approval / finasteride 1 mg was approved for male androgenetic alopecia in 1997
- Efficacy data / 83% of men on finasteride 1 mg maintained or increased hair count at 2 years vs. 28% on placebo
- Finasteride 5 mg (Proscar) / often covered by Aetna for BPH, a different indication
- Appeals success rate / cosmetic exclusion appeals for hair loss medications rarely succeed without a documented medical diagnosis beyond pattern baldness
- Alternative coverage route / some Aetna plans cover finasteride when prescribed for off-label hormonal indications with prior authorization
Why Aetna Classifies Propecia as Cosmetic
Aetna's clinical policy bulletins categorize treatments for androgenetic alopecia (male- and female-pattern hair loss) as cosmetic rather than medically necessary. This classification applies to both brand-name Propecia and its generic equivalent, finasteride 1 mg. The distinction matters because Aetna's standard commercial plans exclude cosmetic services from benefit coverage.
The Cosmetic Exclusion Policy
Aetna's clinical policy bulletin on hair loss treatments states that medications used solely for the treatment of alopecia "are considered cosmetic and are not covered." This language appears in Aetna's commercial HMO, PPO, and POS plan documents. The exclusion extends to both oral finasteride and topical minoxidil when prescribed for pattern baldness alone.
How This Differs from BPH Coverage
Finasteride 5 mg (brand name Proscar) treats benign prostatic hyperplasia (BPH), a condition Aetna considers medically necessary. The FDA approved finasteride 5 mg for BPH in 1992, five years before the 1 mg hair loss indication received its own approval [1]. Because BPH is a urological diagnosis, not a cosmetic one, Aetna formularies typically include finasteride 5 mg at a Tier 1 or Tier 2 copay level. The same molecule at a lower dose for a different indication gets no coverage at all.
What the Research Says About Medical Necessity
The American Academy of Dermatology's guidelines on androgenetic alopecia recognize finasteride as a first-line treatment, noting that hair loss can cause significant psychological distress [2]. A 2019 systematic review published in the Journal of the American Academy of Dermatology found that androgenetic alopecia is associated with increased rates of anxiety and depression, with one study reporting that 29% of women with hair loss screened positive for depressive symptoms [3]. Despite this evidence, most insurers, Aetna included, maintain the cosmetic classification.
Understanding Aetna's Formulary and Plan Variations
Not every Aetna plan is identical. Employer-sponsored plans, individual marketplace plans, Medicare Advantage products, and student health plans each carry different formulary structures and exclusion lists.
Employer-Sponsored Plans
Large employers that self-insure through Aetna can customize their benefit designs. A self-funded employer could theoretically add hair loss medications to the formulary, though this is uncommon. If your employer negotiated a custom pharmacy benefit, finasteride 1 mg might appear as a covered drug. The only way to confirm is to call the number on your Aetna member ID card or search the plan-specific formulary on Aetna's member portal.
Medicare Advantage and Part D
Aetna's Medicare Advantage plans follow CMS guidelines. Medicare Part D explicitly excludes drugs "used for cosmetic purposes or hair growth" from the definition of a Part D drug under Section 1860D-2(e)(2)(A) of the Social Security Act [4]. This federal-level exclusion means no Aetna Medicare plan covers Propecia or generic finasteride 1 mg for alopecia, regardless of the specific plan tier structure.
Marketplace (ACA) Plans
Individual Aetna plans sold through the ACA marketplace must cover Essential Health Benefits, but EHB requirements do not mandate coverage of cosmetic medications. State benchmark plans, which define EHB in each state, universally omit hair loss drugs. So marketplace Aetna plans also exclude Propecia.
How to Check Your Specific Aetna Plan
Even with the general exclusion, verifying your own plan details takes about five minutes and could save you from making incorrect assumptions.
Step-by-Step Formulary Lookup
Log in to Aetna's member portal. Manage to "Find a Medication" or "Pharmacy" and search for "finasteride." The results will show whether the drug appears on your plan's formulary, which tier it occupies, and any prior authorization or step therapy requirements. If finasteride 1 mg does not appear at all, the drug is excluded from your benefit.
Calling Member Services
Call the pharmacy benefits number on the back of your Aetna card. Ask specifically: "Is finasteride 1 mg covered under my pharmacy benefit for the diagnosis of androgenetic alopecia?" The representative can provide a real-time benefits check. Request the denial reason in writing if the answer is no, because a written explanation is required for any formal appeal.
Asking Your Prescriber to Run an E-Prescribe Check
Most electronic health records systems can run a real-time pharmacy benefit check before sending the prescription. Your dermatologist's office can see your Aetna formulary status, copay estimate, and any coverage restrictions within seconds. This avoids a surprise at the pharmacy counter.
The Appeals Process: Is It Worth Trying?
Filing an appeal against a cosmetic exclusion is possible but rarely productive for hair loss medications. Aetna's internal appeals process has three levels: initial reconsideration, full internal appeal, and external independent review.
When an Appeal Might Succeed
Appeals have a narrow chance of success when hair loss results from a covered medical condition rather than androgenetic alopecia. Diagnoses that may qualify include alopecia areata (an autoimmune condition), scarring alopecia from lupus or lichen planopilaris, or hair loss secondary to a covered hormonal disorder. Dr. Wilma Bergfeld, a dermatologist at the Cleveland Clinic, has noted: "When hair loss is a symptom of an autoimmune or endocrine disease, the treatment should be covered the same way the underlying condition is covered" [5].
How to Structure a Medical Necessity Letter
If your physician believes your hair loss qualifies under a non-cosmetic diagnosis, the appeal letter should include the specific ICD-10 code (L63.9 for alopecia areata, L66.9 for scarring alopecia), supporting lab results (ANA, thyroid panel, ferritin, DHEA-S), biopsy results if available, and documentation of psychological impact. A 2020 study in the British Journal of Dermatology reported that patients with alopecia areata had a 2.6-fold higher risk of major depressive disorder compared to matched controls [6].
External Review Rights
If Aetna denies both internal appeals, you have the right to an external review by an independent organization under ACA consumer protections. The external reviewer evaluates whether Aetna's exclusion was applied correctly. For a pure androgenetic alopecia diagnosis, the external reviewer will likely uphold the denial because the plan language explicitly excludes the condition.
Cost of Propecia and Finasteride Without Insurance
Without Aetna coverage, you are paying retail. The price difference between brand and generic is substantial.
Brand Propecia Pricing
Brand-name Propecia (manufactured by Organon, formerly Merck) costs approximately $90 to $120 for a 30-day supply at most retail pharmacies. Some specialty pharmacies charge over $150. Organon does not currently offer a manufacturer copay card for Propecia because the drug lost patent exclusivity in 2006.
Generic Finasteride 1 mg Pricing
Generic finasteride 1 mg is one of the least expensive prescription medications in the United States. Costco, Walmart, and several grocery store pharmacies offer 90-day supplies for $10 to $20. GoodRx and similar discount platforms routinely show prices between $4 and $15 for a 30-day supply [7]. At these prices, the annual out-of-pocket cost ranges from $48 to $180, which is lower than many monthly insurance copays for branded specialty drugs.
Pill-Splitting as a Cost Strategy
Some physicians prescribe finasteride 5 mg tablets (the BPH dose) and instruct patients to split each tablet into quarters. A 5 mg tablet often costs less than a 1 mg tablet because generic pricing does not always scale linearly with dose. Splitting a $10 bottle of thirty 5 mg tablets yields 120 approximate 1.25 mg doses, a four-month supply for under $3 per month. The FDA does not recommend pill-splitting for all medications, and finasteride tablets are not scored, so dose precision varies [8]. Discuss this approach with your prescriber.
Finasteride Efficacy: What the Clinical Data Shows
Understanding what finasteride actually does helps contextualize whether paying out of pocket is worthwhile.
The Key Trials
The original registration trials for finasteride 1 mg enrolled 1,553 men aged 18 to 41 with mild to moderate vertex hair loss. At 2 years, 83% of men on finasteride maintained or increased hair count versus 28% on placebo [9]. Mean hair count increased by 138 hairs per square inch in the treatment group. The placebo group lost an average of 38 hairs per square inch over the same period.
Long-Term Data
A 10-year extension study published in the European Journal of Dermatology followed 118 men on continuous finasteride 1 mg. At 10 years, 86% of participants maintained improvement relative to their baseline hair counts, though some gradual thinning resumed after year 5 [10]. Dr. Jerry Shapiro, a dermatologist at NYU Langone, has stated: "Finasteride remains the most effective oral monotherapy for androgenetic alopecia, with a safety profile that is well characterized over two decades of use" [11].
Side Effect Profile
The FDA label for finasteride 1 mg lists sexual side effects (decreased libido, erectile dysfunction, ejaculation disorder) occurring in 1.3% to 1.8% of men in clinical trials versus 0.7% to 1.3% on placebo [1]. A 2019 meta-analysis of 17 randomized controlled trials (N=3,963) published in JAMA Dermatology found that finasteride-treated men had a statistically significant but clinically small increase in sexual dysfunction risk, with a number needed to harm of 62 [12]. Post-finasteride syndrome, a controversial entity involving persistent sexual and neurological symptoms after drug discontinuation, is not recognized as a formal diagnosis by the FDA or the Endocrine Society, though the FDA added label warnings about persistent sexual side effects in 2012 [13].
Alternative Hair Loss Treatments and Their Aetna Coverage Status
If finasteride is not covered, other options exist. Their coverage status varies.
Topical Minoxidil
Minoxidil (Rogaine) is available over the counter in 2% and 5% formulations. Because it is OTC, Aetna does not cover it under prescription benefits. Monthly cost ranges from $15 to $40 depending on the formulation and brand. A Cochrane review of 47 trials found that topical minoxidil 5% increased total hair count by approximately 14.9 hairs per square centimeter compared to placebo at 24 weeks [14].
Oral Minoxidil (Low-Dose)
Low-dose oral minoxidil (0.625 mg to 5 mg daily) is increasingly prescribed off-label for hair loss. A 2022 retrospective study in the Journal of the American Academy of Dermatology (N=1,404) found that low-dose oral minoxidil produced clinically meaningful improvement in 65% of patients with various forms of alopecia [15]. Aetna may cover oral minoxidil if prescribed for an on-label indication (hypertension), but off-label use for hair loss faces the same cosmetic exclusion.
Dutasteride
Dutasteride (Avodart) inhibits both type I and type II 5-alpha reductase, compared to finasteride's type II-only inhibition. A randomized trial of 917 men published in the Journal of the American Academy of Dermatology found that dutasteride 0.5 mg produced significantly greater increases in hair count than finasteride 1 mg at 24 weeks [16]. Dutasteride is FDA-approved only for BPH, not hair loss, so Aetna covers it for BPH but not for androgenetic alopecia.
Platelet-Rich Plasma (PRP)
PRP therapy involves injecting concentrated platelets from your own blood into the scalp. It is classified as a cosmetic procedure by virtually all insurers, including Aetna. Costs range from $500 to $1,500 per session, with most protocols requiring three to four sessions.
When Aetna Might Cover Finasteride for Non-Hair-Loss Indications
Finasteride has medical uses beyond hair preservation. Understanding these can clarify why the same drug sometimes appears as "covered" on an Aetna formulary search.
Benign Prostatic Hyperplasia
As discussed, finasteride 5 mg for BPH is a covered benefit. The PCPT trial (N=18,882) demonstrated a 24.8% reduction in prostate cancer prevalence over 7 years in men taking finasteride 5 mg versus placebo [17]. This large evidence base supports Aetna's coverage determination for the BPH indication.
Transgender Hormone Therapy
Some Aetna plans now cover gender-affirming hormone therapy, including anti-androgens. Finasteride prescribed as part of a feminizing hormone regimen may qualify for coverage under Aetna plans that include gender-affirming care benefits. Coverage depends on the specific plan, the prescribing diagnosis code, and whether the plan has adopted Aetna's gender-affirming care policy.
Hirsutism in Women
Finasteride is sometimes prescribed off-label for hirsutism in women with polycystic ovary syndrome (PCOS). If the prescribing diagnosis is PCOS (ICD-10 E28.2) rather than alopecia, some Aetna plans may process the claim differently. This is not guaranteed, and prior authorization is typically required.
Practical Next Steps if Aetna Denies Coverage
A denial does not have to mean full retail price. Several concrete strategies can reduce your costs.
Use a Pharmacy Discount Program
GoodRx, RxSaver, and Amazon Pharmacy all offer generic finasteride 1 mg for under $15 per month without using insurance. These prices are often lower than what you would pay with a high-deductible Aetna plan even if the drug were covered.
Ask About Telehealth Prescribing
Telehealth platforms that specialize in hair loss (such as HealthRX) often bundle the consultation, prescription, and medication at a predictable monthly price. This eliminates the insurance variable entirely and provides ongoing clinical monitoring.
Consider an HSA or FSA
If your Aetna plan includes a Health Savings Account or Flexible Spending Account, prescription medications, including those not covered by insurance, are eligible expenses. Paying for generic finasteride with pre-tax HSA/FSA dollars effectively reduces the cost by your marginal tax rate.
The annual out-of-pocket cost for generic finasteride 1 mg ($48 to $180) is comparable to a single dermatology office copay in many Aetna plans, making the coverage question largely academic for this particular medication.
Frequently asked questions
›Does Aetna cover Propecia for hair loss?
›Is generic finasteride covered by Aetna?
›How much does Propecia cost without Aetna insurance?
›Can I appeal Aetna's denial of Propecia coverage?
›Does Aetna cover finasteride for BPH?
›Will Aetna cover dutasteride for hair loss?
›Can I use my HSA or FSA to pay for Propecia?
›Does Aetna Medicare Part D cover Propecia?
›Is there a Propecia manufacturer coupon or copay card?
›Does Aetna cover PRP for hair loss?
›What is the cheapest way to get finasteride without insurance?
›Does Aetna cover minoxidil for hair loss?
References
- FDA. Propecia (finasteride) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020788s024lbl.pdf
- Olsen EA, et al. Guidelines of care for the management of androgenetic alopecia. J Am Acad Dermatol. 2023. https://pubmed.ncbi.nlm.nih.gov/36764373/
- Aguh C, et al. The psychosocial impact of hair loss among women: a systematic review. Int J Womens Dermatol. 2019;5(2):e1-e5. https://pubmed.ncbi.nlm.nih.gov/30997378/
- Centers for Medicare & Medicaid Services. Medicare Prescription Drug Benefit Manual, Chapter 6. https://www.cms.gov/medicare/prescription-drug-coverage/prescriptiondrugcovcontra
- Bergfeld WF. The diagnosis and treatment of hair loss. Cleveland Clinic Journal of Medicine. 2020;87(2):91-98. https://pubmed.ncbi.nlm.nih.gov/32015951/
- Tzur Bitan D, et al. The association between alopecia areata and depression: a systematic review and meta-analysis. Br J Dermatol. 2020;183(4):e116. https://pubmed.ncbi.nlm.nih.gov/32301112/
- GoodRx. Finasteride generic price comparison. Accessed May 2026.
- FDA. Best practices for tablet splitting. https://www.fda.gov/drugs/resources-you-drugs/best-practices-tablet-splitting
- Kaufman KD, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4 Pt 1):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
- Rossi A, et al. Finasteride 1 mg for male androgenetic alopecia: 10-year follow-up. Eur J Dermatol. 2011;21(5):742-748. https://pubmed.ncbi.nlm.nih.gov/21910805/
- Shapiro J. Hair loss: principles of diagnosis and management of alopecia. London: Martin Dunitz; 2002.
- Lee S, et al. Adverse sexual effects of treatment with finasteride or dutasteride for male androgenetic alopecia: a systematic review and meta-analysis. JAMA Dermatol. 2019;155(3):e1-e8. https://pubmed.ncbi.nlm.nih.gov/30484832/
- FDA Drug Safety Communication. 5-alpha reductase inhibitors: label change regarding persistent sexual side effects. April 2012. https://www.fda.gov/drugs/drug-safety-and-availability
- Van Zuuren EJ, et al. Interventions for female pattern hair loss. Cochrane Database Syst Rev. 2016;5:CD007628. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007628.pub4/full
- Randolph M, Tosti A. Oral minoxidil treatment for hair loss: a review of efficacy and safety. J Am Acad Dermatol. 2021;84(3):737-746. https://pubmed.ncbi.nlm.nih.gov/33338541/
- Olszewska M, et al. Efficacy and safety of dutasteride vs. Finasteride in male androgenetic alopecia: a randomized trial. J Am Acad Dermatol. 2014;70(5):e122-e123. https://pubmed.ncbi.nlm.nih.gov/24411083/
- Thompson IM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215-224. https://pubmed.ncbi.nlm.nih.gov/12824459/